You have 9 free searches left this month | for more free features.

Priapism

Showing 1 - 25 of 120

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ManAgement of pRiapiSm and Its Impact on Outcomes

Enrolling by invitation
  • Priapism
    • Catania, CT, Italy
    • +4 more
    Sep 27, 2022

    Priapism Due to Sickle Cell Disease Trial in Kano (Tadalafil, Hydroxyurea, Placebo)

    Recruiting
    • Priapism Due to Sickle Cell Disease
    • Kano, Nigeria
    • +1 more
    Aug 23, 2022

    Priapism Trial in United States (crizanlizumab)

    Recruiting
    • Priapism
    • Birmingham, Alabama
    • +18 more
    Jan 17, 2023

    Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)

    Recruiting
    • Sickle Cell Disease
    • +2 more
    • HDL2
    • Pointe-à-Pitre, Guadeloupe, France
    • +1 more
    Mar 21, 2023

    Sickle Cell Disease Trial in Créteil (Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease)

    Not yet recruiting
    • Sickle Cell Disease
    • Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease
    • Créteil, France
      Hospital Henri Mondor
    Jan 5, 2022

    Via Ischemia of Penis vs Rigiscan. A New Sensor-driven Device to

    Completed
    • Erectile Dysfunction
      • Nieuwegein, Utrecht, Netherlands
        St Antonius Hospital
      Nov 16, 2022

      Sleep Initiation and Maintenance Disorders Trial (QUALI)

      No longer available
      • Sleep Initiation and Maintenance Disorders
      • (no location specified)
      Feb 23, 2023

      Priapism in Boys and Sickle Cell Disease - Demographics,

      Completed
      • Priapism
      • Anemia, Sickle Cell
        • Mobile, Alabama
        • +26 more
        Jan 14, 2019

        After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

        Recruiting
        • Blood and Lymphatic Diseases
        • Detroit, Michigan
          Investigational Site Number :8400001
        Jul 6, 2022

        Retrospective Real World Oxbryta® Data Collection and Analysis

        Completed
        • Sickle Cell Disease
        • Oxbryta® (voxelotor) 500-mg Tablets
        • Farmington, Connecticut
        • +8 more
        Sep 6, 2022

        Sickle Cell Disease, Hemolytic Anemia Trial run by the NHLBI (Mitapivat)

        Active, not recruiting
        • Sickle Cell Disease
        • Hemolytic Anemia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)

        Recruiting
        • Sickle Cell Disease
        • OTQ923
        • Los Angeles, California
        • +4 more
        Jan 9, 2023

        Study of the Role of Genetic Modifiers in Hemoglobinopathies

        Recruiting
        • Sickle Cell Disease
        • +3 more
        • GWAS
        • Boston, Massachusetts
        • +24 more
        Apr 4, 2023

        Sickle Cell Disease Trial in United States (Oxbryta® (voxelotor) 500mg Tablets)

        Recruiting
        • Sickle Cell Disease
        • Oxbryta® (voxelotor) 500mg Tablets
        • Palo Alto, California
        • +9 more
        Dec 15, 2022

        Sickle Cell Disease (SCD) Trial in United States (crizanlizumab)

        Active, not recruiting
        • Sickle Cell Disease (SCD)
        • Orange City, Florida
        • +11 more
        Apr 25, 2022

        GenoMed4ALL: Improving SCD Classification and Prognosis by AI

        Recruiting
        • Sickle Cell Disorders
          • Créteil, France
          • +4 more
          Aug 24, 2023

          Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

          Recruiting
          • Sickle Cell Disease
          • Allogeneic Non-Myeloablative Stem Cell Transplantation
          • +2 more
          • Chicago, Illinois
            University of Illinois at Chicago
          Feb 16, 2022

          Sickle Cell Disease, Hyperbaric Oxygen Therapy, Vaso-occlusive Crisis Trial in Geneva (HBOT in Hyperbaric chamber, Hyperbaric

          Recruiting
          • Sickle Cell Disease
          • +2 more
          • HBOT in Hyperbaric chamber
          • Hyperbaric chamber for placebo
          • Lyon, France
          • +2 more
          Nov 1, 2022

          Kidney Function in Sickle Cell Anemia

          Recruiting
          • Sickle Cell Disease
          • Kidney Failure, Chronic
            • Chapel Hill, North Carolina
            • +2 more
            Jun 11, 2021

            Organic Erectile Dysfunction Trial in Guangzhou (Very small embryonic-like stem cell(VSEL))

            Withdrawn
            • Organic Erectile Dysfunction
            • Very small embryonic-like stem cell(VSEL)
            • Guangzhou, Guangdong, China
              Central laboratory in Fuda cancer hospital
            Oct 13, 2020

            Alcoholism Trial in Madison (Doxazosin, Placebo)

            Completed
            • Alcoholism
            • Madison, Wisconsin
              University of Wisconsin
            Mar 16, 2021

            Sickle Cell Anemia Trial in Worldwide (ACZ885, Placebo)

            Completed
            • Sickle Cell Anemia
            • Atlanta, Georgia
            • +14 more
            Oct 7, 2021

            Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

            Active, not recruiting
            • Melanoma
            • Birmingham, Alabama
            • +209 more
            Nov 14, 2022

            Lung Cancer Trial in Worldwide (Pembrolizumab, Epacadostat, Placebo)

            Completed
            • Lung Cancer
            • Anaheim, California
            • +100 more
            Jan 19, 2022